中国肺癌杂志2011，Vol.14Issue(12)：960-964,5.DOI:10.3779/j.issn.1009-3419.2011.12.11
DNA损伤修复与肺癌顺铂耐药机制的研究进展
Advances of DNA Damage Repair and Cisplatin Resistance Mechanisms in Lung Cancer
摘要
Abstract
Lung cancer is the most common cause of death from cancer worldwide per year. Platinum-based combination chemotherapy is a main treatment of lung cancer. Cisplatin is adopted widely and used effectively in the first-line chemotherapy. Unfortunately, development of cisplatin resistance is a major obstacle to the success of lung caner. Cisplatin is a cell-cycle-non-specific cytotoxic drugs and its main target is DNA. Thus, defective DNA damage repair is one of the main mechanisms of cisplatin resistance. In this review, we will focus on the defective DNA damage repair in cisplatin resistance of lung cancer including nucleotide excision repair, DNA mismatch repair, DNA double-strand break repair and translesion synthesis.关键词
肺肿瘤/顺铂/耐药机制/DNA损伤修复Key words
Lung neoplasms/Cisplatin/Resistance mechanism/DNA damage repair分类
医药卫生引用本文复制引用
唐春兰..DNA损伤修复与肺癌顺铂耐药机制的研究进展[J].中国肺癌杂志,2011,14(12):960-964,5.基金项目
本研究受国家自然基金项目(No.81071913)资助 （No.81071913）
